Investigators assessed the safety and efficacy of Schlemm canal stenting in combination with cataract surgery in eyes with mild to moderate primary open-angle glaucoma (POAG). Source: AAO
Novartis’ brolucizumab (Beovu) is now FDA approved for the treatment of wet AMD, the company reported today. Source: AAO
Researchers evaluated pharmacologic treatment options for visual snow and reported the prevalence of comorbid diseases. Source: AAO
Investigators report the long-term results of accelerated corneal collagen crosslinking (CXL) treatment in adolescent patients with progressive keratoconus. Source: AAO
This systematic review describes the efficacy of conventional and biologic disease-modifying antirheumatic drugs in IgG4-related orbital disease. Source: AAO
This week, a classic card game gets a Braille makeover, researchers call for additional chocolate to confirm its visual benefits and Novartis partners with Microsoft on AI for macular degeneration. Source: AAO
This study examined the mechanism of corneal hydrops in eyes with keratoconus. Source: AAO
This review describes the clinical features that distinguish between major immune-mediated and inflammatory syndromes affecting the brainstem, many of which have ophthalmic effects. Source: AAO
In this study, investigators refine the refractive outcome of the second eye after cataract surgery by deriving adjustment coefficients for IOL selection based on the prediction error (PE) of the first eye. Source: AAO
In this small retrospective chart review, the authors evaluated the effectiveness of gonioscopy-assisted transluminal trabeculotomy (GATT) for steroid-induced glaucoma. Source: AAO
Tel: 518-580-0553
Get Directions »
Tel: 518-580-0553
Get Directions »
Tel: +1 (518) 580-0553
Get Directions »
